Germanium dioxide-induced nephropathy: a new type of renal disease.
Chronic renal failure developed in 5 patients who were taking germanium dioxide (GeO2)-containing compounds. Renal functional deterioration was slow but progressive and dialysis treatment was necessitated temporarily in 2 patients. After the discontinuation of GeO2, the impaired renal function tended to improve but remained abnormal for an observation period of 10-40 months. The lack of proteinuria and hematuria was characterized as the clinical manifestations. Renal biopsy specimens revealed the tubular epithelial cell degeneration containing hematoxylin-positive fine granules on light microscopy, and electron-dense inclusions in the swollen mitochondria on electron microscopy. These findings localized mainly in distal segment of the tubules. In the rats given GeO2 orally for 10 weeks, similar histological lesions were evident, as manifested by marked weight loss, anemia, azotemia, and negative proteinuria. In the rats given carboxyethylgermanium sesquioxide, these changes were not observed and Ge concentration of kidney was significantly lower than in the rats given GeO2. The present study indicates that chronic GeO2 intake causes progressive renal dysfunction characterized by the degeneration of distal tubules.
Sanai
T
T
Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Okuda
S
S
Onoyama
K
K
Oochi
N
N
Oh
Y
Y
Kobayashi
K
K
Shimamatsu
K
K
Fujimi
S
S
Fujishima
M
M
D000293:Adolescent; D000328:Adult; D000818:Animals; D005260:Female; D005857:Germanium / Q000009:adverse effects* / Q000633:toxicity; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D051381:Rats; D011919:Rats, Inbred Strains
D005857:Germanium; C040516:germanium oxide